CH413236A - Process for the preparation of an agent effective against diseases of the oral cavity - Google Patents

Process for the preparation of an agent effective against diseases of the oral cavity

Info

Publication number
CH413236A
CH413236A CH591462A CH591462A CH413236A CH 413236 A CH413236 A CH 413236A CH 591462 A CH591462 A CH 591462A CH 591462 A CH591462 A CH 591462A CH 413236 A CH413236 A CH 413236A
Authority
CH
Switzerland
Prior art keywords
oral cavity
effective against
agent effective
against diseases
preparation
Prior art date
Application number
CH591462A
Other languages
German (de)
Inventor
Stern Max
Willi Dr Doerr
Schmidt Hubertus
Original Assignee
Biochemisches Lab Hubertus Sch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemisches Lab Hubertus Sch filed Critical Biochemisches Lab Hubertus Sch
Publication of CH413236A publication Critical patent/CH413236A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/742Coffea, e.g. coffee
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Tea And Coffee (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Description

  

  
 



  Verfahren zur Herstellung eines gegen Erkrankungen der Mundhöhle wirkenden Mittels
Gegenstand der Erfindung ist ein mikrobiologisches Verfahren zur Herstellung eines gegen Erkrankungen der Mundhöhle, besonders gegen Aphthen wirkenden Mittels.



   Das   erfindungsgemässe    Verfahren ist dadurch gekennzeichnet, dass man die bei Parodontose, Gingivitis, Stomatitis und Aphthen vorhandenen Mundbakterien, die beispielsweise in Form eines Abstriches oder auf andere Weise aus der Mundhöhle entnommen wurden, bei pH 5 bis 7 in einem pulverisierten Rohkaffee, Kohlehydrate und Stickstoffquellen enthaltenden Nährmedium unter nichtsterilen Bedingungen durch Oberflächen- oder Submerskultur fermentiert, das Kulturmedium filtriert und das Filtrat und gegebenenfalls auch das Mycel aufarbeitet.



   Nach entsprechend langem Wachstum bei vorzugsweise etwa 18 bis   24     C, gewöhnlich nach etwa 3 Wochen, ist genügend Perkolat erzeugt, worauf das Kulturmedium nach dem Filtrieren in übliche flüssige oder feste Verarbeitungsformen übergeführt werden kann. Das beim Filtrieren zurückbleibende Mycel kann zu einer Salbe verarbeitet werden.



   Eine besonders vorteilhafte Ausführungsform besteht darin, dass man Wasser mit pulverisiertem Rohkaffee und danach mit Haferflocken versetzt.



  Zum besseren Aufschluss dieser Rohstoffe, insbesondere des Rohkaffees, sollte während der Zugabe dieser Stoffe das Wasser auf einer Temperatur von bis zu etwa 1000 C gehalten werden. Darauf stellt man den pH-Wert, z. B. mit Weinsäure, auf 5 bis 7 ein und beimpft das so hergestellte Nährmedium nach dem Abkühlen auf etwa   70"    C oder darunter mit den Bakterien.



   Zur Durchführung des Verfahrens können die angegebenen Stoffe in etwa den folgenden Mengenverhältnissen verwendet werden: 2 1 Wasser, 250 g Haferflocken,   100 g Rohkaffee,      15 g Weinsäure.   



   Der so hergestellte, physiologisch einwandfreie, d. h. keine unerwünschten Nebenwirkungen hervor  rufende    Wirkstoff stellt ein ausgezeichnetes Mittel zur Bekämpfung von Krankheiten der Mundhöhle, insbesondere von Aphthen, Parodontose, Gingivitis, Stomatitis und jeglichen Arten von Ulcerationen dar.



  Er besitzt gleichzeitig analgetische Eigenschaften und kann intern oder extern angewandt werden.



   Klinische Untersuchungen haben gezeigt, dass sich der nach dem   erfindungsgemässen    Verfahren erzeugte Wirkstoff zur Behandlung aller entzündlichen Prozesse an der Mundschleimhaut, einschliesslich   sämtlicher Zahlfleischentzündiingen,    insbesondere der Gingivitis ulcerosa, und bei dem fast bei allen   Paror    dontosen vorhandenen Entzündungszustand der marginalen Gingiva eignet. Die Behandlung mit dem Wirkstoff führt bei den genannten entzündlichen Zuständen zu einer weitestgehenden Besserung   bzw.,    falls eine Wiederherstellung überhaupt möglich ist, zu einer völligen Heilung. Ganz hervorragend aber bewährte sich seine Anwendung zur Bekämpfung aller Fälle von Aphthen.



   Der nach dem erfindungsgemässen Verfahren erzeugte Wirkstoff zeigt ausserdem überraschende desodorierende Eigenschaften gegenüber den verschiedenartigsten, als   unangenehm    empfundenen   Ge    rüchen, z. B. Mundgerüchen. Falls die desodorierende Wirkung gesteigert werden soll, kann man dem Nährmedium vor der Fermentation noch Chlorophyll oder Chlorophyll enthaltende Substanzen zugeben.



   Man hat schon ein Rohkaffee und Stärke enthaltendes Medium einer Fermentation unter nichtsterilen Bedingungen ausgesetzt. Dieses enthielt jedoch ausserdem Schwefel und war vor der Einwirkung der  von aussen spontan zutretenden Mikroorganismen nicht mit Bakterien beimpft worden. Als Fermentationsprodukt wurde dementsprechend ein völlig anderer, nämlich rheumaspezifischer Wirkstoff mit pharmakologischem Histamingehalt erhalten, der mit dem erfindungsgemäss erhaltenen Wirkstoff nicht vergleichbar ist; seine Herstellung konnte im Hinblick auf das differenzierte Verhalten von Mikroorganismen unter wechselnden Bedingungen auch nicht aus dem bekannten Verfahren abgeleitet werden.   



  
 



  Process for the preparation of an agent effective against diseases of the oral cavity
The subject of the invention is a microbiological process for the production of an agent which is effective against diseases of the oral cavity, especially against aphthous ulcers.



   The method according to the invention is characterized in that the oral bacteria present in periodontal disease, gingivitis, stomatitis and aphthae, which were taken from the oral cavity, for example in the form of a smear or in some other way, at pH 5 to 7 in a pulverized green coffee, carbohydrates and nitrogen sources containing nutrient medium fermented under non-sterile conditions by surface or submerged culture, the culture medium filtered and the filtrate and optionally also the mycelium worked up.



   After a correspondingly long period of growth at preferably about 18 to 24 C, usually after about 3 weeks, sufficient percolate has been produced, whereupon the culture medium can be converted into conventional liquid or solid processing forms after filtering. The mycelium that remains after the filtration can be processed into an ointment.



   A particularly advantageous embodiment consists in adding pulverized raw coffee to water and then adding oat flakes.



  For better digestion of these raw materials, in particular the raw coffee, the water should be kept at a temperature of up to about 1000 C while these substances are being added. The pH value is then set, e.g. B. with tartaric acid, to 5 to 7 and inoculate the nutrient medium produced in this way after cooling to about 70 ° C or below with the bacteria.



   To carry out the process, the specified substances can be used in approximately the following proportions: 2 liters of water, 250 g of oat flakes, 100 g of green coffee, 15 g of tartaric acid.



   The physiologically flawless, d. H. Active ingredient that does not cause undesirable side effects is an excellent means of combating diseases of the oral cavity, in particular aphthae, periodontal disease, gingivitis, stomatitis and all kinds of ulcerations.



  It also has analgesic properties and can be used internally or externally.



   Clinical investigations have shown that the active ingredient produced by the method according to the invention is suitable for the treatment of all inflammatory processes on the oral mucosa, including all inflammation of the flesh, in particular ulcerative gingivitis, and in the inflammation of the marginal gingiva that is present in almost all periodontoses. Treatment with the active ingredient leads to the most extensive improvement in the mentioned inflammatory conditions or, if recovery is at all possible, to complete healing. However, its use for combating all cases of aphthae has proven to be very good.



   The active ingredient produced by the process according to the invention also shows surprising deodorant properties against the most varied of odors that are perceived as unpleasant Ge, eg. B. Bad breath. If the deodorizing effect is to be increased, chlorophyll or substances containing chlorophyll can also be added to the nutrient medium before fermentation.



   A medium containing green coffee and starch has already been subjected to fermentation under non-sterile conditions. However, this also contained sulfur and had not been inoculated with bacteria prior to the action of the microorganisms spontaneously entering from the outside. A completely different, namely rheumatoid-specific active ingredient with a pharmacological histamine content, which is not comparable with the active ingredient obtained according to the invention, was accordingly obtained as the fermentation product; its production could not be derived from the known process with regard to the differentiated behavior of microorganisms under changing conditions.

 

Claims (1)

PATENTANSPRUCH Verfahren zur Herstellung eines gegen Erkrankungen der Mundhöhle, besonders gegen Aphthen wirkendenMittels, dadurch gekennzeichnet, dass man die bei Parodontose, Gingivitis, Stomatitis und Aphthen vorhandenen Mundbakterien bei pH 5 bis 7 in einem pulverisierten Rohkaffee, Kohlenhydrate und Stickstoffquellen enthaltenden Nährmedium unter nichtsterilen Bedingungen durch Oberflächen- oder Submerskultur fermentiert, das Kulturmedium filtriert und mindestens das Filtrat aufarbeitet. PATENT CLAIM Process for the production of an agent effective against diseases of the oral cavity, especially against aphthous ulcers, characterized in that the oral bacteria present in periodontal disease, gingivitis, stomatitis and aphthous ulcers are passed through surfaces at pH 5 to 7 in a powdered raw coffee, carbohydrates and nitrogen sources under non-sterile conditions - Fermented or submerged culture, the culture medium filtered and at least the filtrate worked up. UNTERANSPRUCH Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man das Filtrat und das Mycel aufarbeitet. SUBClaim Method according to claim, characterized in that the filtrate and the mycelium are worked up.
CH591462A 1961-06-20 1962-05-16 Process for the preparation of an agent effective against diseases of the oral cavity CH413236A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB62958A DE1149857B (en) 1961-06-20 1961-06-20 Process for the preparation of an agent effective against diseases of the oral cavity

Publications (1)

Publication Number Publication Date
CH413236A true CH413236A (en) 1966-05-15

Family

ID=6973790

Family Applications (1)

Application Number Title Priority Date Filing Date
CH591462A CH413236A (en) 1961-06-20 1962-05-16 Process for the preparation of an agent effective against diseases of the oral cavity

Country Status (6)

Country Link
BE (1) BE618110A (en)
CH (1) CH413236A (en)
DE (1) DE1149857B (en)
DK (1) DK107573C (en)
GB (1) GB984897A (en)
LU (1) LU41888A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960702988A (en) * 1993-06-23 1996-06-19 스티븐 씨. 휴스턴 IMPROVED CHEWING GUM AND CANDY PRODUCTS
FR2779345B1 (en) * 1998-06-03 2003-02-14 Fabre Pierre Dermo Cosmetique USE OF MICROORGANISM EXTRACTS IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS FOR INHIBITING BODY ODORS

Also Published As

Publication number Publication date
LU41888A1 (en) 1962-08-16
GB984897A (en) 1965-03-03
DK107573C (en) 1967-06-12
DE1149857B (en) 1963-06-06
BE618110A (en) 1962-09-17

Similar Documents

Publication Publication Date Title
DE2524355C2 (en) Tetrahydropyran derivatives, processes for their preparation and pharmaceuticals containing these compounds
DE4134854C2 (en)
DE3049773C2 (en) Process for the production of pectin from plant tissues
DE2731570C3 (en) Process for obtaining a polysaccharide with therapeutic effect
DE2138453A1 (en) Process for extracting useful substances from the hyphae of edible mushrooms
DE2167325C2 (en) Antibiotic A-201B and process for its preparation
CH413236A (en) Process for the preparation of an agent effective against diseases of the oral cavity
DE1949719C2 (en) Microbiological production of dextranase
DE2319989A1 (en) STABILIZED ENZYME PREPARATION, METHOD FOR ITS MANUFACTURING AND USE
DE2938377C2 (en) Process for the preparation of coenzyme Q 1 0
DE1944493A1 (en) Process for the production of pentitols
DE1642622A1 (en) Process for the production of a new ferment for curdling milk
AT208999B (en) Process for the manufacture of pimaricin
DE3004018C2 (en)
DE887933C (en) Process for the preparation of 2-keto-h-idonic acid
DE803593C (en) Process for the production of a yeast which is particularly suitable for extract production
DE3617368C2 (en) Process for the preparation of a nitrogenous polysaccharide
DE1517749C3 (en) Process for the production of dry preparations of phosphotransacetylase from Escherichia coli which can be kept for a long time at room temperature
DE869679C (en) Process for the production and extraction of an antibiotic substance
DE2813547A1 (en) GLUCAN AND METHOD FOR PRODUCING THIS GLUCAN
AT233737B (en) Process for the production of an antibiotic from propionic acid bacteria
AT373144B (en) AGENT AGAINST THE GRAYING OF THE HAIR AND METHOD FOR THE PRODUCTION THEREOF
DE554000C (en) Process for the preparation of dioxyacetone through the bacterial conversion of glycerine
AT269363B (en) Process for the production of a production strain of a Claviceps purpurea (Fr.) Tul. Culture for the production of ergot alkaloids
DE2308059C3 (en) Process for the biosynthetic production of griseofulvin